Cancer Health Treatment Update Women Are at Greater Risk for Cancer Treatment Side Effects Compared with men, women had a 34% greater likelihood of adverse events, especially if they received immunotherapy. How the Gut Microbiome Affects Cancer Treatment Microorganisms in the gut influence how the body responds to common cancer treatments, including immunotherapy. Investigating the Connections Between Medicaid and Cancer Survival Many people with cancer enroll in Medicaid only after they are diagnosed, suggesting they previously had limited access to cancer screening and treatment. When Symptoms Linger for Weeks, Is It Long COVID? Though such cases may not always amount to debilitating long COVID, it is common to take weeks to fully recover. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Advertisement Cancer Health Reader Survey Your opinion matters! Please take our survey and let Cancer Health know which topics are important to you.  Cancer Health Spring 2022 Check out our latest print edition! Newsfeed Experts Recommend Fifth COVID-19 Vaccination for Immunocompromised People Children of Patients with Cancer More Likely to Experience Medical Financial Hardship Acknowledging the Fears of Cancer by Giving Them a Face and a Name Concerning Decline in Annual Screening for Breast Cancer Survivors Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia Newsfeed Experts Recommend Fifth COVID-19 Vaccination for Immunocompromised People Children of Patients with Cancer More Likely to Experience Medical Financial Hardship Acknowledging the Fears of Cancer by Giving Them a Face and a Name Concerning Decline in Annual Screening for Breast Cancer Survivors Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: